Back to Journals » Drug Design, Development and Therapy » Volume 16
Retraction
A Novel Glycyrrhetinic Acid-Modified Oxaliplatin Liposome for Liver-Targeting and in vitro/vivo Evaluation [Retraction]
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
2,271 | Dovepress* | 2,187+ | 45 | 2,232 | |
PubMed Central* | 84 | 42 | 126 | ||
Totals | 2,271 | 87 | 2,358 | ||
*Since 18 November 2022 |
View citations on PubMed Central and Google Scholar